Optimal management of diabetic foot osteomyelitis: challenges and solutions

José Luis Lázaro Martínez, Yolanda García Álvarez, Aroa Tardáguila-García, Esther García MoralesInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad Complutense...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lázaro Martínez JL, García Álvarez Y, Tardáguila-García A, García Morales E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/63b9d33864434173880ced8fc2d69d0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:63b9d33864434173880ced8fc2d69d0a
record_format dspace
spelling oai:doaj.org-article:63b9d33864434173880ced8fc2d69d0a2021-12-02T04:53:12ZOptimal management of diabetic foot osteomyelitis: challenges and solutions1178-7007https://doaj.org/article/63b9d33864434173880ced8fc2d69d0a2019-06-01T00:00:00Zhttps://www.dovepress.com/optimal-management-of-diabetic-foot-osteomyelitis-challenges-and-solut-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007José Luis Lázaro Martínez, Yolanda García Álvarez, Aroa Tardáguila-García, Esther García MoralesInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid 28040, SpainPurpose: Diabetic foot osteomyelitis (DFO) is the most frequent infection associated with diabetic foot ulcers, occurs in >20% of moderate infections and 50%–60% of severe infections, and is associated with high rates of amputation. DFO represents a challenge in both diagnosis and therapy, and many consequences of its condition are related to late diagnosis, delayed referral, or ill-indicated treatment. This review aimed to analyze the current evidence on DFO management and to discuss advantages and disadvantages of different treatment options.Methods: A narrative review of the evidence was begun by searching Medline and PubMed databases for studies using the keywords “management”, “diabetic foot”, “osteomyelitis”, and “diabetic foot osteomyelitis” from 2008 to 2018.Results: We found a great variety of studies focusing on both medical and surgical therapies showing a similar rate of effectiveness and outcomes; however, the main factors in choosing one over the other seem to be associated with the presence of soft-tissue infection or ischemia and the clinical presentation of DFO.Conclusion: Further randomized controlled trials with large samples and long-term follow-up are necessary to demonstrate secondary outcomes, such as recurrence, recurrent ulceration, and reinfection associated with both medical and surgical options.Keywords: diabetic foot, diabetic foot infection, bone infection, diabetic foot ulcersLázaro Martínez JLGarcía Álvarez YTardáguila-García AGarcía Morales EDove Medical Pressarticlediabetic footdiabetic foot infectionbone infectiondiabetic foot ulcersSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 947-959 (2019)
institution DOAJ
collection DOAJ
language EN
topic diabetic foot
diabetic foot infection
bone infection
diabetic foot ulcers
Specialties of internal medicine
RC581-951
spellingShingle diabetic foot
diabetic foot infection
bone infection
diabetic foot ulcers
Specialties of internal medicine
RC581-951
Lázaro Martínez JL
García Álvarez Y
Tardáguila-García A
García Morales E
Optimal management of diabetic foot osteomyelitis: challenges and solutions
description José Luis Lázaro Martínez, Yolanda García Álvarez, Aroa Tardáguila-García, Esther García MoralesInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid 28040, SpainPurpose: Diabetic foot osteomyelitis (DFO) is the most frequent infection associated with diabetic foot ulcers, occurs in >20% of moderate infections and 50%–60% of severe infections, and is associated with high rates of amputation. DFO represents a challenge in both diagnosis and therapy, and many consequences of its condition are related to late diagnosis, delayed referral, or ill-indicated treatment. This review aimed to analyze the current evidence on DFO management and to discuss advantages and disadvantages of different treatment options.Methods: A narrative review of the evidence was begun by searching Medline and PubMed databases for studies using the keywords “management”, “diabetic foot”, “osteomyelitis”, and “diabetic foot osteomyelitis” from 2008 to 2018.Results: We found a great variety of studies focusing on both medical and surgical therapies showing a similar rate of effectiveness and outcomes; however, the main factors in choosing one over the other seem to be associated with the presence of soft-tissue infection or ischemia and the clinical presentation of DFO.Conclusion: Further randomized controlled trials with large samples and long-term follow-up are necessary to demonstrate secondary outcomes, such as recurrence, recurrent ulceration, and reinfection associated with both medical and surgical options.Keywords: diabetic foot, diabetic foot infection, bone infection, diabetic foot ulcers
format article
author Lázaro Martínez JL
García Álvarez Y
Tardáguila-García A
García Morales E
author_facet Lázaro Martínez JL
García Álvarez Y
Tardáguila-García A
García Morales E
author_sort Lázaro Martínez JL
title Optimal management of diabetic foot osteomyelitis: challenges and solutions
title_short Optimal management of diabetic foot osteomyelitis: challenges and solutions
title_full Optimal management of diabetic foot osteomyelitis: challenges and solutions
title_fullStr Optimal management of diabetic foot osteomyelitis: challenges and solutions
title_full_unstemmed Optimal management of diabetic foot osteomyelitis: challenges and solutions
title_sort optimal management of diabetic foot osteomyelitis: challenges and solutions
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/63b9d33864434173880ced8fc2d69d0a
work_keys_str_mv AT lazaromartinezjl optimalmanagementofdiabeticfootosteomyelitischallengesandsolutions
AT garciaalvarezy optimalmanagementofdiabeticfootosteomyelitischallengesandsolutions
AT tardaguilagarciaa optimalmanagementofdiabeticfootosteomyelitischallengesandsolutions
AT garciamoralese optimalmanagementofdiabeticfootosteomyelitischallengesandsolutions
_version_ 1718401008586981376